Feng, Yahui
Qi, Saibing
Liu, Xueou
Zhang, Li
Hu, Yu
Shen, Qiujin
Gong, Xiaowen
Zhang, Wei
Wang, Junxia
Yan, Wen
Wang, Tiantian
Wang, Huijun
Song, Zhen
Zhu, Xiaofan http://orcid.org/0000-0002-2572-6495
Gale, Robert Peter http://orcid.org/0000-0002-9156-1676
Chen, Junren http://orcid.org/0000-0003-3691-4931
Funding for this research was provided by:
the Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences
Ministry of Science and Technology of the People's Republic of China (2019YFA0110803, 84000-51200002)
DH | National Institute for Health Research (Not applicable)
Ministry of Science and Technology of the People's Republic of China
Article History
Received: 21 July 2023
Revised: 30 August 2023
Accepted: 5 September 2023
First Online: 13 September 2023
Competing interests
: RPG is a consultant to Antengene Biotech LLC, Ascentage Pharma Group and NexImmune Inc.; Medical Director, FFF Enterprises Inc.; Board of Directors: Russian Foundation for Cancer Research Support; and Scientific Advisory Boards, Nanexa AB and StemRad Ltd.
: Approved by the Academic Committee (IIT-NI2020001) and Ethics Review Committee (NI2020001-EC-1) of the Institute of Hematology, Chinese Academy of Medical Sciences (IHCAMS). Subjects gave written informed consent consistent with precepts of the Helsinki Declaration.